↓ Skip to main content

Cediranib (recentin, AZD2171) reverses ABCB1- and ABCC1-mediated multidrug resistance by inhibition of their transport function

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, March 2009
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
36 Mendeley
Title
Cediranib (recentin, AZD2171) reverses ABCB1- and ABCC1-mediated multidrug resistance by inhibition of their transport function
Published in
Cancer Chemotherapy and Pharmacology, March 2009
DOI 10.1007/s00280-009-0949-1
Pubmed ID
Authors

Li-yang Tao, Yong-ju Liang, Fang Wang, Li-ming Chen, Yan-yan Yan, Chun-ling Dai, Li-wu Fu

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Unknown 35 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 19%
Student > Ph. D. Student 6 17%
Student > Bachelor 5 14%
Student > Master 4 11%
Other 2 6%
Other 6 17%
Unknown 6 17%
Readers by discipline Count As %
Agricultural and Biological Sciences 9 25%
Biochemistry, Genetics and Molecular Biology 7 19%
Pharmacology, Toxicology and Pharmaceutical Science 5 14%
Medicine and Dentistry 5 14%
Psychology 1 3%
Other 3 8%
Unknown 6 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 June 2016.
All research outputs
#7,856,604
of 23,815,455 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#688
of 2,501 outputs
Outputs of similar age
#33,986
of 95,429 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#9
of 18 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,501 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 95,429 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.